China · Delayed Price · Currency is CNY Shenzhen Chipscreen Biosciences Company Description
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the pharmaceutical industry in China.
The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for peripheral T-cell lymphoma, breast cancer, and diffuse large B-cell lymphoma indications; Chiglitazar, a PPAR full agonist for diabetes treatment; Siglitazone for metabolism treatment area; and Cioronib, a novel molecular, which selectively inhibits tumor-related protein kinase targets.
It is also involved in the development of CS23546, a small molecule PD-L1 inhibitor, which relieves the immunosuppressive activity mediated by the PD-1/PD-L1 signaling pathway; CS231295, a brain-penetrating selective Aurora B inhibitor; and CS32582, a small-molecule allosteric inhibitor of tyrosine kinase 2.
In addition, the company develops CS08399, a potential brain-penetrating PRMT5-MTA inhibitor for BIC; CS12088, a hepatitis B nucleocapsid assembly modulator; and CS12192, a highly selective JAK3 kinase inhibitor.
Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is headquartered in Shenzhen, China.
| Country | China |
| Founded | 2001 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,002 |
| CEO | Jian-Xun Li |
Contact Details
Address: Zhigu Industrial Park Shenzhen, 518057 China | |
| Phone | 86 755 2695 2070 |
| Website | chipscreen.com |
Stock Details
| Ticker Symbol | 688321 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003LW0 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Xian-Ping Lu | Founder and Chairman |
| Jian-Xun Li BA.CFA | President, Head of Finance and Director |
| Dr. Desi Pan | Vice President, Deputy GM and Chief Scientific Officer |
| Dr. Zhi-Bin Li Ph.D. | Executive Vice President and Head of Product Development and Production |
| Liangji She | Executive Vice President and Head of the Commercial Segment |
| Ou Hai | Vice President, Deputy GM, Secretary of the Board and Director |
| Dr. Leming Shi | Co-Founder |
| Dr. Weiming Hu | Co-Founder |
| Ji-Hui Yi MS | Vice President of Sales and Marketing |